Examples of using L-dopa in English and their translations into Swedish
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
L-DOPA is an amino acid, so protein competitively inhibits L-DOPA absorption.
L-DOPA crosses the protective blood-brain barrier,
L-DOPA is produced from the amino acid L-tyrosine by the enzyme tyrosine hydroxylase.
Dopamine is formed by the decarboxylation of L-DOPA by aromatic L-amino acid decarboxylase AADC.
The human body produces only one of these isomers the L-DOPA form.
How can we counter involuntary movements in L-DOPA treatment of patients with Parkinson's disease?
Furthermore, L-DOPA itself mediates neurotrophic factor release by the brain and CNS.
L-DOPA increases dopamine.
L-DOPA crosses the protective blood- brain barrier, whereas dopamine itself cannot.
gave subjects L-DOPA.
L-DOPA, can be transformed to dopamine by the enzyme DOPA decarboxylase.
The two types of response seen with administration of L-DOPA are: The short-duration response is related to the half-life of the drug.
L-DOPA is a key compound in the formation of marine adhesive proteins, such as those found in mussels.
L-DOPA can be directly metabolized by catechol-O-methyl transferase to 3-O-methyldopa,
The enantiomeric purity of L-DOPA may be analyzed by determination of the optical rotation
The enzyme tyrosinase catalyzes the oxidation of L-DOPA to the reactive intermediate dopaquinone, which reacts further,
L-DOPA may also be used to prevent surfaces from fouling by bonding antifouling polymers to a susceptible substrate.
Once L-DOPA has entered the central nervous system, it is converted into dopamine by the enzyme aromatic L-amino acid decarboxylase, also known as DOPA decarboxylase.
L-DOPA is used to increase dopamine concentrations in the treatment of Parkinson's disease and dopamine-responsive dystonia.
Herbal extracts containing L-DOPA are available;